Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04441619 · ClinicalTrials.gov registry record · NA
Mechanisms and Modulation of Pain Modulatory Capacity
A NA study of Musculoskeletal Pain, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT04441619: Recruiting NA study of Musculoskeletal Pain, sponsored by University of Florida.
NCT04441619 is a NA study of Musculoskeletal Pain that is actively recruiting participants, run by University of Florida. The registered enrollment target is 180 participants, above the 151-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04441619, a NA study of Musculoskeletal Pain, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This project proposes to understand the sources of pain variability, and demonstrate that pain variability represents fluctuation in natural pain management. The project further proposes to determine if endogenous capacity to modulate pain can be trained to maximize their body's ability to manage pain, much as the way in which athletic performance can be trained.
Primary Outcome
Pain during movement and pain at rest using the visual analog scale (VAS). Scores are recorded every day by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain.
Conditions Studied
Interventions
- BEHAVIORAL Delayed onset muscle soreness.
Study Locations (1)
Florida
- Unversity of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2020-11-30 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT04441619 shows while recruiting
NCT04441619 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 151-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (19% higher).
The record links to 1 condition, with Musculoskeletal Pain appearing as the primary indexed condition, and to 1 intervention - of which Delayed onset muscle soreness. is the first listed.
NCT04441619 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04441619 about?
NCT04441619 is a clinical study titled "Mechanisms and Modulation of Pain Modulatory Capacity". This project proposes to understand the sources of pain variability, and demonstrate that pain variability represents fluctuation in natural pain management. The project further proposes to determine if endogenous capacity to modulate pain can be trained to maximize their body's ability to manage pa...
What is the current status of trial NCT04441619?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2020-11-30. Estimated completion is 2026-04-30.
What conditions does trial NCT04441619 study?
This clinical trial studies the following conditions: Musculoskeletal Pain.
What interventions are being tested in trial NCT04441619?
The interventions under investigation include: Delayed onset muscle soreness. (BEHAVIORAL).
Who is sponsoring clinical trial NCT04441619?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04441619 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Musculoskeletal Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04441619's enrollment target sits among peer trials
180 14th of 37 higher than 24 of 37 other Musculoskeletal Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Musculoskeletal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Neural Mechanisms of Light Driven Analgesia
RECRUITING · NA
-
Equipping Patients Using Interventions for Pain and Depression
RECRUITING · NA
-
Online Yoga vs Acceptance and Commitment Therapy for Treating Chronic Musculoskeletal Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI